These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 8979530)

  • 1. Deterioration of carbohydrate metabolism by nifedipine.
    Gupta N; Ansari KU
    Indian J Med Sci; 1996 Jun; 50(6):201-3. PubMed ID: 8979530
    [No Abstract]   [Full Text] [Related]  

  • 2. Nifedipine, a calcium-channel blocker, attenuated glucose intolerance and white adipose tissue dysfunction in type 2 diabetic KK-A(y) mice.
    Iwai M; Kanno H; Inaba S; Senba I; Sone H; Nakaoka H; Horiuchi M
    Am J Hypertens; 2011 Feb; 24(2):169-74. PubMed ID: 20847723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of nifedipine, captopril and prazosin on secretory function of pancreatic beta-cells in hypertensive patients with type-2 (non-insulin-dependent) diabetes and in hypertensive non-diabetics.
    Jasik M; Kasperska-Dworak A; Czyzyk A
    Diabetes Res Clin Pract; 1996 Jun; 33(1):59-66. PubMed ID: 8877277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Influence of a calcium channel blocker, nicardipine, on glucoregulatory hormones and glucose metabolism].
    Tanioka F; Ishihara H; Kotani N; Sakai T; Kudo M; Matsuki A; Oyama T
    Masui; 1986 Jan; 35(1):78-83. PubMed ID: 3520039
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effects of calcium antagonists on carbohydrate and lipid metabolism].
    Preobrazhenskiĭ DV; Fomichev VI; Afanas'ev AIa
    Kardiologiia; 1992 Apr; 32(4):84-9. PubMed ID: 1405247
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of nifedipine on severe experimental cataract in diabetic rats.
    Kametaka S; Kasahara T; Ueo M; Takenaka M; Saito M; Sakamoto K; Nakahara T; Ishii K
    J Pharmacol Sci; 2008 Apr; 106(4):651-8. PubMed ID: 18431041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcium antagonists and blood glucose in normal rabbits.
    Patel RB; Shah GF; Raval JD; Gandhi TP; Gilbert RN
    Arzneimittelforschung; 1987 Apr; 37(4):410-2. PubMed ID: 3300662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of calcium-blockers nicardipine, darodipine, PN-200-110 and nifedipine on insulin release from isolated rat pancreatic islets.
    Al-Mahmood HA; el-Khatim MS; Gumaa KA; Thulesius O
    Acta Physiol Scand; 1986 Feb; 126(2):295-8. PubMed ID: 2939690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Acute administration of calcium antagonists: effects on various parameters of glyco-lipid metabolism].
    Bonetti A; Campana M; Cerioli GC; Solito F; Tirelli F; Zuliani U
    G Clin Med; 1987 May; 68(5):289-92. PubMed ID: 3305123
    [No Abstract]   [Full Text] [Related]  

  • 10. The calcium channel blocker LAS 30538, unlike nifedipine, verapamil, diltiazem or flunarizine, potently inhibits insulin secretion in-vivo in rats and dogs.
    Gristwood RW; Furman BL; Llenas J; Jauregui J; Berga P
    J Pharm Pharmacol; 1992 Oct; 44(10):851-5. PubMed ID: 1360513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antihyperglycemic action of angiotensin II receptor antagonist, valsartan, in streptozotocin-induced diabetic rats.
    Chan P; Wong KL; Liu IM; Tzeng TF; Yang TL; Cheng JT
    J Hypertens; 2003 Apr; 21(4):761-9. PubMed ID: 12658023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of calcium channel antagonists in modifying the inhibitory influence of adenosine on insulin secretion.
    Ismail NA; Shaheen AA; el-Sawalhi MM; Megahed YM
    Arzneimittelforschung; 1995 Aug; 45(8):865-8. PubMed ID: 7575748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of calcium antagonists on insulin-mediated glucose metabolism in skeletal muscle.
    Foot EA; Leighton B
    Diabetes; 1994 Jan; 43(1):73-9. PubMed ID: 8262320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impairment of insulin secretion in man by nifedipine.
    Giugliano D; Torella R; Cacciapuoti F; Gentile S; Verza M; Varricchio M
    Eur J Clin Pharmacol; 1980 Nov; 18(5):395-8. PubMed ID: 7002569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Ca2(+)-channel agonists and antagonists on skeletal muscle sugar transport.
    Westfall MV; Sayeed MM
    Am J Physiol; 1990 Feb; 258(2 Pt 2):R462-8. PubMed ID: 1689966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition by calcium antagonist of coupling of insulin binding and insulin action on glucose transport in isolated fat cells.
    Ishibashi F; Kubo K
    Hiroshima J Med Sci; 1984 Mar; 33(1):73-9. PubMed ID: 6384143
    [No Abstract]   [Full Text] [Related]  

  • 17. Influence of calcium channel blocker treatment on the mechanical properties of diabetic rat myocardium.
    Brown RA; Lee MM; Sundareson AM; Woodbury DJ; Savage AO
    Acta Diabetol; 1996 Mar; 33(1):7-14. PubMed ID: 8777289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of dihydropyridine sensitive calcium channels in glucose transport in skeletal muscle.
    Young JC; Balon TW
    Life Sci; 1997; 61(3):335-42. PubMed ID: 9217294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetes-associated cognitive impairment is improved by a calcium channel blocker, nifedipine.
    Tsukuda K; Mogi M; Li JM; Iwanami J; Min LJ; Sakata A; Fujita T; Iwai M; Horiuchi M
    Hypertension; 2008 Feb; 51(2):528-33. PubMed ID: 18195165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid large artery remodeling following the administration and withdrawal of calcium channel blockers in spontaneously hypertensive rats.
    Vaja V; Ochodnicky P; Krenek P; Klimas J; Bajuszova Z; Kyselovic J
    Eur J Pharmacol; 2009 Oct; 619(1-3):85-91. PubMed ID: 19683522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.